This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...

An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...

The Sultanate of Oman is the third country worldwide to implement this project, confirming its commitment to technological ...

In an era where chronic diseases are reshaping global health priorities, the diabetic retinopathy market stands out as a ...

Diabetic retinopathy happens when elevated blood sugar levels cause damage to the blood vessels in the retina. The retina plays a crucial role in transmitting visual images to the brain.

Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of ...

The cross-sectional analysis of 359,126 patients with type 1 and type 2 diabetes, published online on June 13, 2024, in JAMA Ophthalmology, found the prevalence of diabetic retinopathy (DR ...